| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 2417-75-6 | 4-(溴甲基)-1-萘甲酸甲酯 | Methyl 4-(bromomethyl)-1-naphthoate | C13H11BrO2 | 279.13 | 75-76 °C | 391.3±25.0 °C(Predicted) |
| 2417-77-8 | | 9-bromomethyl-anthracen | C15H11Br | 271.15 | 143-146°C | 411.7°C |
| 2417-85-8 | | Arsine,tris[2-methylphenyl]- | C21H21As | 348.31 | | |
| 2417-90-5 | 溴乙基氰 | -Bromopropionitrile | C3H4BrN | 133.98 | | 76-78℃(1 |
| 24170-14-7 | | 1-octadecanaminium, n-(carboxymethyl)-n,n-bis(2-hydroxyethyl)-, hydroxide, inne | | | | |
| 24170-48-7 | | propanenitrile, 3-[(2-hydroxyethyl)[4-[[6-(methylsulfonyl)-2-benzothiazolyl]azo | | | | |
| 24170-60-3 | N-[2-[(2-氰基-4,6-二硝基苯)偶氮]-5-(二乙基氨)苯基]乙酰胺 | N-[2-[(2-cyano-4,6-dinitrophenyl)azo]-5-(diethylamino)phenyl]-Acetamide | C19H19N7O5 | | | |
| 2417014-06-1 | 5-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)-4-(三氟甲基)嘧啶 | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyrimidine | C11H14BF3N2O2 | 274.0473 | | |
| 2417089-74-6 | XL177A | | C48H57ClN8O5 | 861.46 | | |
| 24171-03-7 | 2,5-二氨基-1,4-二羟基苯二盐酸盐 | 2,5-DIAMINOHYDROQUINONE DIHYDROCHLORIDE | C6H10Cl2N2O2 | 213.06 | | |
| 24171-27-5 | | 2-butylaminoethyl methacrylate | | | | |
| 24171-66-2 | | isoquinoline picrate | | | | |
| 24171-85-5 | | ethyl 4-(hydroxyamino)benzoate | | | | |
| 24171-89-9 | | tris(2-thienyl)phosphine | C12H9PS3 | 280.35 | 29℃ | 205 °C / 2mmHg |
| 2417174-67-3 | tert-Butyl (1-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-2-oxo-6,9,12-trioxa-3-azatetradecan-14-yl)carbamate | | C28H38N4O11 | 606.63 | | |
| 2417213-21-7 | (11bS)-N-(2,6-双(4-(叔丁基)苯基)-4-氧化二萘并[2,1-d:1',2'-f][1,3,2]二氧杂磷杂环庚-4-基)-1,1,1三氟甲磺酰胺 | (11bS)-N-(2,6-Bis(4-(tert-butyl)phenyl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide | C41H37F3NO5PS | 743.77 | | 783.0±70.0 °C(Predicted) |
| 2417226-02-7 | 1-(1-bicyclo[1.1.1]pentanyl)-4-iodo-pyrazole | | C8H9N2I | 260.0741 | | |
| 2417226-05-0 | methyl 3-(4-bromopyrazol-1-yl)bicyclo[1.1.1]pentane-1-carboxylate | | C10H11N2O2Br | 271.1101 | | |
| 2417226-93-6 | 1-(1-bicyclo[1.1.1]pentanyl)-4-bromo-pyrazole | | C8H9N2Br | 213.0741 | | |
| 2417234-65-0 | 4,4''-二氨基-[1,1':4',1''-三联苯]-2',5'-二羧酸 | 4,4''-Diamino-[1,1':4',1''-terphenyl]-2',5'-dicarboxylic acid | C20H16N2O4 | 348.35 | | 606.2±55.0 °C(Predicted) |
| 2417256-16-5 | m-PEG15-acetic acid | | C33H66O18 | 750.9 | | |
| 2417296-84-3 | Compound 23 | | C48H54F2N10O10S | 1001.08 | | |
| 24173-08-8 | | 1,2,3,4-tetrabromo-2-methyl-butane | C5H8Br4 | 387.73 | | |
| 24173-36-2 | | 4-azido-benzaldehyd | C7H6N3O | 147.13 | | |
| 24173-43-1 | 5-甲基-2-(对甲苯氨基)苯甲酸 | 5-methyl-2-(p-tolylamino)benzoic acid | C15H15NO2 | 241.29 | | |
| 24173-47-5 | | 3,7-dimethyl-6-nonen-1-yn-3-o | | | | |
| 2417302-02-2 | 7-溴-1H-吲哚-6-甲酰胺 | 7-Bromo-1H-Indole-6-Carboxamide | C9H7BrN2O | 239.07 | | |
| 2417302-07-7 | 鲁拉西酮杂质94 | SY-5609 | | | | |
| 2417321-37-8 | (4R,5S)-2-(6-甲基吡啶-2-基)-4,5-二苯基-4,5-二氢恶唑 | (4R,5S)-2-(6-Methylpyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole | C21H18N2O | 314.38 | | |
| 2417321-38-9 | (4R,5R)-4,5-二苯基-2-(喹啉-2-基)-4,5-二氢恶唑 | (4R,5R)-4,5-Diphenyl-2-(quinolin-2-yl)-4,5-dihydrooxazole | C24H18N2O | 350.4100 | | |
| 2417321-41-4 | (4S,5R)-2-(6-甲氧基吡啶-2-基)-4,5-二苯基-4,5-二氢噁唑 | (4S,5R)-2-(6-methoxypyridin-2-yl)-4,5-diphenyl-4,5-dihydroox | C21H18N2O2 | 330.3800 | | |
| 2417369-94-7 | PROTAC ERα Degrader-1 | | C66H69N7O10 | 1120.29 | | |
| 2417370-42-2 | PROTAC BRD4 Degrader-9 | | C59H71F2N9O15S4 | 1312.50 | | |
| 2417370-49-9 | PROTAC BRD4 Degrader-10 | | C59H71F2N9O15S4 | 1312.50 | | |
| 2417370-67-1 | PROTAC BRD4 Degrader-15 | | C57H62F2N10O10S2 | 1149.29 | | |
| 2417370-71-7 | PROTAC BRD4 Degrader-13 | | C68H85F2N11O17P2S2 | 1492.54 | | |
| 2417370-90-0 | PROTAC BRD4 Degrader-12 | | C62H77F2N9O12S4 | 1306.58 | | |
| 2417371-71-0 | GNE-987 | | C56H67F2N9O8S2 | 1096.31 | | |
| 2417387-47-2 | 4,7-dibromo-1,3-dihydroisobenzofuran | | C8H6OBr2 | 277.9404 | | |
| 2417408-14-9 | | | | | | |
| 2417408-46-7 | N-(4-((2-(4-(6-((6-乙酰基-8-环戊基-5-甲基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-2-基)氨基)吡啶-3-基)哌嗪-1-基)-2-氧代乙基)氨基)丁基)-2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酰胺 | N-(4-((2-(4-(6-((6-Acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazin-1-yl)-2-oxoethyl)amino)butyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide | C45H51N11O9 | 889.95 | | |
| 2417416-71-6 | 2-bromo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine hydrochloride | | C6H8N3Br.HCl | 238.5124 | | |
| 2417419-28-2 | 3,6-二溴-1,4-二甲基喹啉-2(1H)-酮 | 3,6-Dibromo-1,4-dimethylquinolin-2(1H)-one | C11H9Br2NO | 331 | | 372.1±42.0 °C(Predicted) |
| 2417456-70-1 | | [s(R)]-n-[(S)-[2-(diphenylphosphino)-4,5-dimethoxyphenyl)](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide | C32H36NO4PS | 561.7 | | |
| 2417456-74-5 | [S(R)]-N-[(S)-[2-(二苯基膦)-4,5-二甲氧基苯基]-1-萘基甲基]-2-叔丁基亚磺酰胺 | (R)-N-((S)-(2-(Diphenylphosphanyl)-4,5-dimethoxyphenyl)(naphthalen-1-yl)methyl)-2-methylpropane-2-sulfinamide | | | | |
| 2417471-76-0 | 双(1-甲基乙基)N-[(1S)-1-(苯基甲基)-2-(1-哌啶基)乙基]磷酰胺 | Bis(1-methylethyl) N-[(1S)-1-(phenylmethyl)-2-(1-piperidinyl)ethyl]phosphoramidate | C20H35N2O3P | 382.48 | | |
| 2417471-78-2 | N-[(1S)-1-(苯基甲基)-2-(1-哌啶基)乙基]磷酰胺二乙酯 | Diethyl N-[(1S)-1-(phenylmethyl)-2-(1-piperidinyl)ethyl]phosphoramidate | C18H31N2O3P | 354.42 | | |
| 2417471-79-3 | N-[(1S)-2-甲基-1-(1-哌啶基甲基)丙基]磷酰胺二乙酯 | Diethyl N-[(1S)-2-methyl-1-(1-piperidinylmethyl)propyl]phosphoramidate | C14H31N2O3P | 306.38 | | |
| 2417489-10-0 | RP-3500 | Camonsertib | C21H26N6O3 | 410.48 | | |
| 2417489-41-7 | 6-氯-1H-吡咯并[2,3-b]吡啶-4-羧酸乙酯 | Ethyl 6-chloro-1H-pyrrolo[2,3-b]pyridine-4-carboxylate | C10H9ClN2O2 | 224.647 | | |
m.cnreagent.com